(Q41657338)

6 October 2017

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. (English)

1 reference

6 October 2017

Golumbek PT

1

1 reference

6 October 2017

Lazenby AJ

2

1 reference

6 October 2017

Levitsky HI

3

1 reference

6 October 2017

Jaffee LM

4

1 reference

6 October 2017

Karasuyama H

5

1 reference

6 October 2017

Baker M

6

1 reference

6 October 2017

Pardoll DM

7

1 reference

6 October 2017

language of work or name

English

0 references

publication date

1 November 1991

1 reference

6 October 2017

4

1 reference

based on heuristic

inferred from page(s)

published in

Science

1 reference

6 October 2017

254

1 reference

6 October 2017

713-716

1 reference

6 October 2017

5032

1 reference

Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus

6 October 2017

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/0092-8674(83)90344-6

Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/EJI.1830180115

Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1.

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/315333A0

Introduction of soluble protein into the class I pathway of antigen processing and presentation

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/S0092-8674(88)91043-4

Identifiers

DOI

10.1126/SCIENCE.1948050

1 reference

6 October 2017

0 references

1 reference